How Long Does 2.5 mg of THC Stay in Your System?

A single 2.5 mg dose of THC, roughly the size of a low-dose edible or a therapeutic microdose, will typically clear a standard urine screening within one to three days for someone who rarely uses cannabis. But that estimate shifts dramatically depending on what kind of test you face, how often you have used cannabis in the past, and even how your body stores fat. The gap between when THC stops affecting you and when it stops showing up on a test is wider than most people expect.

What Happens to 2.5 mg of THC in Your Body

After you swallow an edible or capsule containing 2.5 mg of THC, the compound is absorbed through your gut and carried to your liver. There, most of it is either eliminated or broken down into two main metabolites: 11-OH-THC, which is psychoactive, and 11-COOH-THC (also called THC-COOH), which is not psychoactive but sticks around much longer.¹ THC-COOH is what most urine drug tests actually look for. The THC itself and its active metabolite peak in your blood a few hours after an oral dose, but the inactive metabolite lingers in your system far longer.

THC is highly fat-soluble, which means your body pulls it out of the bloodstream quickly and tucks it away in fatty tissue. The plasma half-life of THC, or the time it takes for blood levels to drop by half, ranges from roughly one to three days in occasional users and can stretch to five to thirteen days in chronic users.¹ For a one-time 2.5 mg dose, you are firmly on the shorter end of that range, but the fat-storage mechanism is the reason THC metabolites linger far longer than you might guess from the brief high.

Urine Testing and the Cutoff That Matters

Urine tests are the most common type you will encounter for employment or legal purposes, and they don’t look for THC itself. They screen for THC-COOH. The critical variable is the cutoff concentration the lab uses, and different cutoffs produce very different detection windows.

In a controlled study of single-dose marijuana exposure, mean detection times ranged from half a day at a 100 ng/mL cutoff after a low dose, to about one and a half days at the same cutoff after a higher dose. Dropping the cutoff to 50 ng/mL extended detection to under two days after the higher dose. At the most sensitive cutoff tested, 20 ng/mL, detection stretched from one to five days after the low dose and three to six days after the higher dose.² Most workplace drug screens use a 50 ng/mL immunoassay as the initial screen, so for a single 2.5 mg oral dose in an infrequent user, you are looking at roughly one to two days to clear that threshold.

If the initial screen flags a positive, labs typically run a confirmatory test using GC-MS with a lower cutoff, often 15 ng/mL. Confirmation testing roughly doubled the detection times compared to the 50 ng/mL immunoassay screen in the same study.² Different immunoassay brands also vary in sensitivity and specificity, so the exact cutoff concentration on one manufacturer’s test doesn’t perfectly predict results on another.³ The practical takeaway: if you are an occasional user and took a single 2.5 mg edible, a standard workplace urine test is unlikely to catch it after about three days, but using a more sensitive cutoff could push that closer to a week.

Blood and Saliva Tests

Blood tests detect THC itself, not just its metabolites, so they have a much shorter detection window after a single low dose. THC peaks in your blood within a few hours of oral ingestion and drops off relatively fast. For an occasional user, a 2.5 mg dose would produce quite low peak blood levels, and THC would fall below detectable thresholds within hours to a day or so. A study examining very low oral THC doses, in the range of 0.05 to 0.09 mg delivered in hemp oil, found that no THC was detected in blood, oral fluid, or urine at any time point.⁴ Those doses were far smaller than 2.5 mg, so that result doesn’t directly apply, but it shows how sharply detection depends on the amount ingested.

Saliva tests, sometimes called oral fluid tests, are increasingly used in roadside screening. After smoking cannabis, THC stays detectable in saliva for a surprisingly long time. In one study, all specimens remained THC-positive for at least 13.5 hours after a single smoked session, and median last-detection times stretched beyond 24 hours for both frequent and occasional smokers.⁵ Oral dosing changes the picture somewhat. When cannabis is eaten rather than smoked, there is less direct THC contamination of the mouth, so initial oral fluid levels tend to be lower. However, metabolites like 11-OH-THC and THC-COOH appear more frequently in oral fluid after oral dosing compared to inhaled routes in occasional users, widening the metabolite detection window even though peak THC concentrations may be lower.⁶ For a 2.5 mg edible, expect saliva THC to be detectable for roughly 12 to 24 hours, though this is harder to pin down than urine detection because saliva testing protocols and cutoffs vary more widely.

The Surprising Hair Test Result

Hair tests are supposed to be the long-game detector, catching cannabis use from weeks or months ago. But for oral THC at a 2.5 mg dose, the evidence is striking: it might not show up at all. In a study where two volunteers took 2.5 mg of dronabinol (pharmaceutical THC) three times daily for 30 days, totaling 7.5 mg per day over a full month, no THC was detected in any head hair, beard hair, or body hair samples at any point during the study period.⁷ That is a cumulative dose far higher than a single 2.5 mg serving, yet it produced zero detectable signal.

The reason has to do with how THC gets into hair. THC that enters your bloodstream after oral consumption reaches hair follicles only in very small amounts. By contrast, smoked or vaporized cannabis deposits THC directly onto hair strands through smoke and handling, and it can also be transferred through sweat and skin oils. That same study found that external contamination from cannabis smoke was a more reliable route of THC into hair than internal metabolism via the bloodstream.⁷ So if your sole exposure is a 2.5 mg edible, a hair test is very unlikely to pick it up.

Why Your Usage History Matters More Than the Dose

Here is where the question “how long does 2.5 mg stay in your system” gets complicated. That dose matters, but your history of cannabis use matters more. If you are a daily or near-daily user, your fat tissue is already saturated with THC from previous sessions. Each new dose adds to that reservoir, and the metabolites leach out slowly. Chronic daily smokers can have detectable THC in their blood for weeks after they stop. In one study, only one of eleven chronic daily users tested negative for blood THC by day 26, and two of five participants still had detectable THC at day 30.⁸ THC-COOH persisted even longer: four out of five participants still tested positive after 30 days, and one remained positive at 33 days.⁸

Even occasional but non-daily users carry some residual THC between sessions. Blood THC can be measured up to a month after the last intake in heavy users.⁹ So if you are asking about a single 2.5 mg dose in isolation with no prior use, the timelines discussed earlier apply. But if you took that 2.5 mg on top of regular cannabis use, it is the accumulated burden in your fat stores that drives your detection window, not the size of the most recent dose.

Body Fat, Exercise, and THC Release

Because THC parks itself in fat tissue, people with more body fat tend to retain it longer. This is well established as a general principle, though quantifying exactly how many extra days a higher body-fat percentage adds is difficult because so many other variables are in play simultaneously.

A more interesting wrinkle involves what happens when stored THC gets released. Animal research has shown that conditions promoting lipolysis, the breakdown of fat for energy, can push THC back out of fat cells and into the bloodstream. Both food deprivation and stress hormone exposure raised blood THC levels in rats that had been chronically dosed with the drug.¹⁰ Similarly, exercise increased plasma THC concentrations in regular human cannabis users.¹¹

Before you panic about a workout causing a failed drug test, the practical picture is more reassuring than the headlines suggest. A follow-up study in rats found that while food deprivation and exercise both increased levels of the metabolite THC-COOH, neither actually raised plasma THC itself.¹² And in a human study, urinary metabolite ratios declined during exercise and food deprivation, with no discernible spikes corresponding to the timing of those activities. The researchers concluded that moderate exercise and short-term fasting are unlikely to cause interpretational difficulties for urinary drug testing.¹³ In short, going for a jog or skipping lunch before a test is not going to sabotage an otherwise clean urine result, especially after a single low dose.

Product Formulation Changes How Much THC You Actually Absorb

Not all 2.5 mg doses are created equal. The form your THC comes in affects how much actually reaches your bloodstream, which in turn influences how long it hangs around. Standard oil-based edibles and capsules have relatively low bioavailability because THC is broken down significantly during its first pass through the liver. But newer formulations are designed to dodge some of that first-pass metabolism.

A crossover study comparing a nanoemulsifying powder delivery system with a standard oil-based formulation found that the nanoemulsion produced more than double the peak plasma concentrations of THC and its active metabolite 11-OH-THC, and reached those peaks faster.¹⁴ What this means is that 2.5 mg in a nano-emulsified gummy could put roughly twice as much THC into your blood as 2.5 mg in a traditional oil-based edible. Higher peak blood levels likely translate to slightly longer detection windows, though no study has measured detection times head-to-head for different formulations at identical doses. If you are cutting it close on timing before a test, the delivery format is worth considering.

Detection Does Not Equal Impairment

One of the most persistent misunderstandings is that a positive drug test means you are impaired. For THC, detection and impairment are strikingly disconnected. After inhaling cannabis, blood THC concentrations typically return to baseline well before the subjective and cognitive effects wear off.¹⁵ In other words, you can be clearly impaired while your blood THC is low, and you can have detectable THC while completely sober.

The reverse problem is equally real for frequent users. A study of 30 subjects who abstained from cannabis for 12 hours found that 16 of them still had blood THC concentrations above 5 ng/mL, a common legal limit for driving, despite showing no measurable impairment.¹⁶ This gap between detection and impairment is the reason that per se THC driving limits, laws that make it illegal to drive above a certain blood THC level regardless of impairment, remain scientifically controversial. For someone who took a 2.5 mg edible, the impairment from such a small dose would likely be mild and short-lived, perhaps two to four hours. But a sensitive enough test could still pick up metabolites well after you feel completely normal.

Genetic Variation in THC Metabolism

Your liver enzymes determine how fast THC is broken down, and not everyone’s enzymes work at the same speed. The CYP2C9 enzyme plays a major role in converting THC to its metabolites. People carrying certain genetic variants of this enzyme, specifically CYP2C9*2 and CYP2C9*3, showed significantly lower concentrations of the metabolite THC-COOH and higher ratios of THC to THC-COOH compared to people with the standard version of the gene.¹⁷ In practical terms, these “slow metabolizers” break down THC less efficiently, meaning THC itself hangs around in their blood longer while less metabolite accumulates.

A more recent study looking at CYP2C9 and CYP2C19 genotypes after controlled cannabis consumption found no statistically significant differences in blood concentrations across predicted metabolizer types, though trends in the expected direction were visible for CYP2C9 variants.¹⁸ The effect probably exists but is modest enough that real-world variability in body composition, usage history, and test sensitivity tends to swamp the genetic signal. You are unlikely to know your CYP2C9 status unless you have had pharmacogenomic testing, and even if you are a slow metabolizer, the difference for a single 2.5 mg dose is probably a matter of hours, not days.

Secondhand Smoke and Passive Exposure

If your concern is whether you could test positive after being in a room with people smoking cannabis rather than consuming 2.5 mg yourself, the evidence is mostly reassuring. A controlled study exposing non-smokers to extreme secondhand cannabis smoke found no positive urine results at the standard 50 ng/mL cutoff except for a single specimen. At the lower 20 ng/mL cutoff, multiple positives did occur, but only in the hours immediately after exposure, and only under conditions where the smoke exposure was obvious and intense.¹⁹ Casual secondhand exposure, like being at a party where someone lights up across the room, is extremely unlikely to produce a positive test under standard screening conditions.

Biological Sex and THC Processing

Research in rodents has uncovered sex-based differences in how THC is metabolized. Female rats metabolized THC more selectively through one pathway, while males produced a wider variety of metabolites.²⁰ Mouse studies found that females had higher peak plasma THC and 11-OH-THC concentrations than males after receiving the same oral dose, with females also reaching peak THC levels earlier.²¹ Whether these animal findings translate cleanly to humans is still unclear. Women tend to carry a higher percentage of body fat than men, which could mean more THC storage and slower clearance, but rigorous human studies controlling for dose, body composition, and usage history simultaneously are scarce. For a single 2.5 mg dose in an infrequent user, any sex-based difference in clearance time is likely small enough to be outweighed by the other factors discussed above.

1
PubMed Central. Mechanisms of Action and Pharmacokinetics of Cannabis
2
Journal of Analytical Toxicology. Detection Times of Marijuana Metabolites in Urine by Immunoassay and GC-MS
3
Forensic Science International. Correlations on radioimmunoassay, fluorescence polarization immunoassay, and enzyme immunoassay of cannabis metabolites with gas chromatography/mass spectrometry analysis of 11-nor-Δ9-tetrahydrocannabinol-9-carboxylic acid in urine specimens
4
Forensic Science International. Detection of delta-9-tetrahydrocannabinol (THC) in oral fluid, blood and urine following oral consumption of low-content THC hemp oil
5
PubMed Central. Oral fluid cannabinoid concentrations following controlled smoked cannabis in chronic frequent and occasional smokers
6
PubMed Central. Cannabinoid disposition in oral fluid after controlled smoked, vaporized, and oral cannabis administration
7
Scientific Reports. Finding cannabinoids in hair does not prove cannabis consumption
8
PubMed Central. Impact of prolonged cannabinoid excretion in chronic daily cannabis smokers’ blood on per se drugged driving laws
9
PubMed. Δ9-tetrahydrocannabinol (THC) is present in the body between smoking sessions in occasional non-daily cannabis users
10
PubMed Central. Reintoxication: the release of fat-stored delta(9)-tetrahydrocannabinol (THC) into blood is enhanced by food deprivation or ACTH exposure
11
PubMed. Exercise increases plasma THC concentrations in regular cannabis users
12
Psychopharmacology. Fasting and exercise increase plasma cannabinoid levels in THC pre-treated rats: an examination of behavioural consequences
13
PubMed Central. Can Physical Exercise or Food Deprivation Cause Release of Fat-Stored Cannabinoids?
14
PubMed Central. Enhancing cannabinoid bioavailability: a crossover study comparing a novel self-nanoemulsifying drug delivery system and a commercial oil-based formulation
15
PubMed Central. Assessment of cognitive and psychomotor impairment, subjective effects, and blood THC concentrations following acute administration of oral and vaporized cannabis
16
PubMed Central. Indeterminacy of cannabis impairment and ∆(9)-tetrahydrocannabinol (∆(9)-THC) levels in blood and breath
17
PubMed Central. Toxicogenetic analysis of Δ9-THC-metabolizing enzymes
18
PubMed Central. Assessing the influence of CYP2C9 and CYP2C19 genotypes on the metabolism of CBD-cannabis after controlled single and repetitive consumption
19
PubMed Central. Non-Smoker Exposure to Secondhand Cannabis Smoke. I. Urine Screening and Confirmation Results
20
PubMed. Sex difference in the oxidative metabolism of delta 9-tetrahydrocannabinol in the rat
21
bioRxiv. Sex differences in plasma, adipose tissue, and central accumulation of cannabinoids, and behavioural effects of oral cannabis consumption in male and female C57BL/6 mice